+34 620 10 75 37info@nanbiosis.com

Platform Unit 4. Preclinical Validation: Bioimaging

Platform Unit 4 give support in the preclinical developmente of new therapeutic compounds by validating new therapeutic targets and/or nanotherapies by using optical image techniques and NMR.
Some of the funtcions of this platfor are:

  • Analysis of fagocytic behavior and interactions of cells in poresence of magnetic nanoparticled therapeutic agents.
  • Spectroscopies for ain vivo applications and for apllications in biofluids, tissues and biomaterials.
    • In vivo Validation, visualization and quantification of therapeutic agents tested and visualization and quantification of the induced tissue regeneration at real time.
    • Validation of new therapeutic targets.
  • In vivo Validation, visualization and quantification of celular and genetic activities dealing with pathologies at real time.